Abbott agrees to buy Alere at lower price from earlier offer

Go back to Abbott agrees to buy Alere at lower price from earlier offer

Alere (ALR) PT Lowered to $51 at Canaccord Genuity

April 17, 2017 9:27 AM EDT

Canaccord Genuity lowered its price target on Alere (NYSE: ALR) to $51.00 (from $52.00) while maintaining a Buy rating. ABT and ALR announced a settlement at $51/share, or ~21% higher than ALR's closing price of $42.31 last Thursday.

Canaccord believes that shareholders would have approved anything at $50+ so... More

Alere (ALR) PT Lowered to $51 at Jefferies Following Announced Revisions to ABT Merger

April 17, 2017 7:17 AM EDT

Jefferies lowered its price target on Alere (NYSE: ALR) to $51.00 (from $56.00) while maintaining a Hold rating following the company's announced amended the terms of to the merger with ABT.

Key revisions include: 1) $51/share vs. the original $56; 2) timeline extended to September 30 from April 30; and... More

Abbott (ABT) to Acquire Alere (ALR) for $51/Share in Amended Agreement

April 17, 2017 6:12 AM EDT

Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced Friday that the companies have agreed to amend the existing terms of their agreement for Abbott's acquisition of Alere.

Under the amended terms, Abbott will pay $51 per common... More